| The genetic landscape and epidemiology of phenylketonuria A Hillert, Y Anikster, A Belanger-Quintana, A Burlina, BK Burton, ... The American Journal of Human Genetics 107 (2), 234-250, 2020 | 203 | 2020 |
| Tetrahydrobiopterin treatment in phenylketonuria: A repurposing approach RAF Evers, D van Vliet, FJ van Spronsen Journal of Inherited Metabolic Disease 43 (2), 189-199, 2020 | 20 | 2020 |
| The first European guidelines on phenylketonuria: Usefulness and implications for BH4 responsiveness testing RAF Evers, AMJ van Wegberg, K Anjema, CMA Lubout, E van Dam, ... Journal of inherited metabolic disease 43 (2), 244-250, 2020 | 16 | 2020 |
| Effect of BH4 on blood phenylalanine and tyrosine variations in patients with phenylketonuria AMJ van Wegberg, RAF Evers, JGM Burgerhof, E van Dam, ... Molecular genetics and metabolism 133 (1), 49-55, 2021 | 11 | 2021 |
| Anthropomorphic measurements and nutritional biomarkers after 5 years of BH4 treatment in phenylketonuria patients RAF Evers, AMJ van Wegberg, E van Dam, MC de Vries, MCH Janssen, ... Molecular genetics and metabolism 124 (4), 238-242, 2018 | 11 | 2018 |
| Does the 48-hour BH4 loading test miss responsive PKU patients? AMJ van Wegberg, RAF Evers, E van Dam, MC de Vries, MCH Janssen, ... Molecular Genetics and Metabolism 129 (3), 186-192, 2020 | 8 | 2020 |
| Dietary Liberalization in Tetrahydrobiopterin-Treated PKU Patients: Does It Improve Outcomes? RAF Evers, AMJ van Wegberg, A MacDonald, SCJ Huijbregts, V Leuzzi, ... Nutrients 14 (18), 3874, 2022 | 2 | 2022 |
| Defining tetrahydrobiopterin responsiveness in phenylketonuria: Survey results from 38 countries RAF Evers, AMJ van Wegberg, K Ahring, S Beblo, A Bélanger-Quintana, ... Molecular genetics and metabolism 132 (4), 215-219, 2021 | 2 | 2021 |
| A decade of tetrahydrobiopterin treatment for phenylketonuria: An evaluation RAF Evers | | 2023 |
| Risk factors of metabolic syndrome, and micronutrient status in sapropterin-treated phenylketonuria patients: a retrospective cohort study R Evers | | 2017 |
